ASK1 was activated in CLL cells treated with flavopiridol in vitro as well as in vivo (from patients who received flavopiridol, thus indicating relevance of these findings to the clinic) [17]. Here, MAP3K5 is linked to B-cell chronic lymphocytic leukemia.